AMY BETH DOUNAY

Person

COLORADO SPRINGS, CO, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 11,964,961
- Issue date Apr 23, 2024
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 11,014,909
- Issue date May 25, 2021
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,696,658
- Issue date Jun 30, 2020
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,421,744
- Issue date Sep 24, 2019
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,093,655
- Issue date Oct 9, 2018
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,077,272
- Issue date Sep 18, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,868,744
- Issue date Jan 16, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,856,263
- Issue date Jan 2, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,822,097
- Issue date Nov 21, 2017
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,617,275
- Issue date Apr 11, 2017
- Pfizer Inc.
- Jotham Wadsworth Coe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,527,831
- Issue date Dec 27, 2016
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,527,843
- Issue date Dec 27, 2016
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,139,561
- Issue date Sep 22, 2015
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,133,190
- Issue date Sep 15, 2015
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,107,923
- Issue date Aug 18, 2015
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
KAT II inhibitors
- Patent number 8,933,095
- Issue date Jan 13, 2015
- Pfizer Inc.
- Amy Beth Dounay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 8,822,494
- Issue date Sep 2, 2014
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
KAT II inhibitors
- Patent number 8,598,200
- Issue date Dec 3, 2013
- Pfizer Inc.
- Amy B Dounay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
KAT II inhibitors
- Patent number 8,487,104
- Issue date Jul 16, 2013
- Pfizer Inc.
- Amy B Dounay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic and tricyclic compounds as KAT II inhibitors
- Patent number 8,183,238
- Issue date May 22, 2012
- Pfizer Inc.
- Michelle M. Claffey
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20240317713
- Publication date Sep 26, 2024
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20210300899
- Publication date Sep 30, 2021
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20200283407
- Publication date Sep 10, 2020
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20190367485
- Publication date Dec 5, 2019
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20190002439
- Publication date Jan 3, 2019
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180346477
- Publication date Dec 6, 2018
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180072750
- Publication date Mar 15, 2018
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180037571
- Publication date Feb 8, 2018
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20170165270
- Publication date Jun 15, 2017
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170057947
- Publication date Mar 2, 2017
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170037053
- Publication date Feb 9, 2017
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170037049
- Publication date Feb 9, 2017
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20150344490
- Publication date Dec 3, 2015
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150344474
- Publication date Dec 3, 2015
- Pfizer Inc.
- JENNIFER ELIZABETH DAVOREN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150307522
- Publication date Oct 29, 2015
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20150291625
- Publication date Oct 15, 2015
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150196561
- Publication date Jul 16, 2015
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150175573
- Publication date Jun 25, 2015
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS KAT II INHIBITORS
- Publication number 20150175603
- Publication date Jun 25, 2015
- Pfizer Inc.
- Amy Beth Dounay
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150005313
- Publication date Jan 1, 2015
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20140336176
- Publication date Nov 13, 2014
- Pfizer Inc.
- JENNIFER ELIZABETH DAVOREN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20140128374
- Publication date May 8, 2014
- Pfizer Inc.
- JENNIFER ELIZABETH DAVOREN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KAT ll INHIBITORS
- Publication number 20140057938
- Publication date Feb 27, 2014
- Pfizer Inc.
- AMY BETH DOUNAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KAT ll INHIBITORS
- Publication number 20120302599
- Publication date Nov 29, 2012
- Pfizer Inc.
- Amy B. Dounay
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KAT ll INHIBITORS
- Publication number 20120142729
- Publication date Jun 7, 2012
- Pfizer Inc.
- AMY B. DOUNAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Mod...
- Publication number 20120053165
- Publication date Mar 1, 2012
- Pfizer Inc.
- Martin Patrick Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic And Tricyclic Compounds As KAT II Inhibitors
- Publication number 20100324043
- Publication date Dec 23, 2010
- Pfizer Inc.
- Michelle M. Claffey
- C07 - ORGANIC CHEMISTRY

AMY BETH DOUNAY

Person

Patents Grantslast 30 patents

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

KAT II inhibitors

Heteroaromatic compounds and their use as dopamine D1 ligands

KAT II inhibitors

KAT II inhibitors

Bicyclic and tricyclic compounds as KAT II inhibitors

Patents Applicationslast 30 patents

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

TRICYCLIC COMPOUNDS AS KAT II INHIBITORS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

KAT ll INHIBITORS

KAT ll INHIBITORS

KAT ll INHIBITORS

Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Mod...

Bicyclic And Tricyclic Compounds As KAT II Inhibitors